IMAX Imax Corporation Common Stock
NYSE · Media · View on SEC EDGAR ↗ 10-K/10-Q Jul 23, 2026IMAX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
IMAX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| May 27, 1997 | 2-for-1 | Forward |
About Imax Corporation Common Stock Company overview from Wikipedia
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it is headquartered in Mississauga in the Greater Toronto Area, with operations in New York City and Los Angeles.
As of November 2025, there were 1,759 IMAX theatres located in 90 countries, of which 1,693 were in commercial multiplexes. These include IMAX variations such as IMAX 3D, IMAX Dome, and Digital IMAX. The CEO is Richard Gelfond.
History
IMAX is a Canadian corporation that is based in Mississauga, Ontario. The company was founded in 1967 when three filmmakers—Graeme Ferguson, Roman Kroitor and Robert Kerr—incorporated IMAX Corporation. The idea and the new technology, which resulted in the birth of the company, came from the multi-screen productions of Roman Kroitor, Colin Low and Hugh O'Connor. In the Labyrinth and Ferguson's Man and the Polar Regions (on which Robert Kerr collaborated), both screened at the Expo 67. From their experience, Graeme Ferguson, Roman Kroitor and Robert Kerr realized that new technology would be necessary to develop a larger and more complex project than previously seen. As a result, they sought an engineer named William Shaw in 1968 (he had gone to Galt Collegiate Institute in Galt, Ontario, now Cambridge, with Ferguson and Kerr) to help develop this technology. Shaw created this new projector that allowed for films to have exceptional quality and to be ten times larger than conventional 35mm picture frames. The first movie IMAX Corporation produced using this new technology was Tiger Child, which was featured at Expo '70 in Osaka, Japan. It was because of the multi-screen viewing that Graeme Ferguson, Roman Kroitor and Robert Kerr wanted to create a theatre with giant screens, surround sound and stadium seating.
William Shaw was instrumental in helping IMAX Corporation fulfill its ambitions in creating larger and more realistic experiences for audience which included oversized screens, surround sound and steep seating for better viewing. Shaw remained at IMAX (although officially retired) as a designer and inventor until his death on August 31, 2002, at the age of 73. Before retiring, Shaw created a 3D camera which was sent to the International Space Station for IMAX films. In 1994, investment bankers Gelfond and Bradley Wechsler acquired IMAX Corporation through a leveraged buyout and publicly listed the company on the NASDAQ stock exchange. IMAX then began to focus their abilities on attracting Hollywood production houses. Another engineer at IMAX Corporation, Brian Bonnick, Chief Technology Officer at IMAX Corporation, developed technologies that made it possible for the worldwide IMAX to produce major Hollywood films. More flexible technology required by that industry led to the development of the IMAX DMR (Digital Re-Mastering), which was able to adapt quickly in various locations. Newer technology followed, including the IMAX Experience and the IMAX MPX theatre system. Revamped IMAX 2D footage has been transferred into IMAX 3D. In September 2022, IMAX Corporation acquired streaming technology company Ssimwave for $21 million in a cash and stock deal.
Recent milestones
In April 2009, Gelfond became the sole IMAX CEO and Wechsler moved into the role of chairman of the board of directors.
Later in 2009, IMAX participated in the movie Avatar, to which the company credits its mainstream Hollywood success.
In March 2011, IMAX noted that China's Wanda Cinema Line announced a 75-theatre deal with IMAX Corporation.
In 2012, IMAX opened its first location in Tianjin, China.
On October 8, 2015, IMAX China, a subsidiary of the company, was listed on the Hong Kong Stock Exchange. According to The Hollywood Reporter and The Wall Street Journal, "IMAX China raised $248 million in its initial public offering," which was the "bottom of [the] indicative price range."
As of December 2019, there were 1,624 theatres in 81 countries and territories.
Co-productions
In November 2016, Marvel Television and IMAX announced the live action television series Marvel's Inhumans, based on the superhero race of the same name. The series, co-produced with ABC Studios, saw IMAX serve as a financing partner, a first for IMAX, which allowed Marvel to spend more on the series than it had on its other television series, especially for visual effects. The entire series was filmed with IMAX digital cameras. Inhumans debuted an edited specific for theatrical-release version of the first two episodes. The episodes debuted on IMAX screens in theatres worldwide in September 2017, with the series airing weekly on ABC afterwards. After the poor reception to the IMAX version of the first two episodes and a box office gross of $3.5 million, Richard Gelfond said, "Going forward, we intend to take a more conservative approach consistent with the Game of Thrones approach to capital investments and content. We will be more conservative when considering whether to invest our own capital; and if so, to what extent."
Business
IMAX generates revenue primarily through two segments: Technology Products and Services, and Content Solutions.
Theater systems: sales, rentals, and revenue sharing
IMAX theater systems are installed under several different commercial arrangements. Under a joint revenue sharing arrangement (JRSA), IMAX installs a system at little or no upfront cost to the exhibitor and instead takes a percentage of gross box office receipts; as of 2026, slightly under half of the company's roughly 1,876 locations operated under this model.
Content Solutions and DMR
IMAX's Content Solutions business generates revenue primarily through DMR (Digital Media Remastering) conversion fees for remastering conventional films for IMAX release, typically around 12.5% of a film's gross box office receipts, with lower rates in Greater China. The company's theater network grew from 299 locations in 2008, when the introduction of digital projection allowed systems to be retrofitted into existing multiplexes without the cost of new construction, to approximately 1,876 locations by 2026.
IMAX Enhanced
In September 2018, IMAX and DTS launched IMAX Enhanced, a licensing and certification program for home entertainment products and content. Modeled on THX's home-theater certification program, IMAX Enhanced certifies audio-video hardware that meets defined performance standards and pairs it with IMAX-remastered 4K high-dynamic-range content, using a variant of the DTS:X audio codec. Launch partners included Sony Electronics, Sony Pictures, Paramount Pictures, and Sound United (parent of Denon and Marantz). For example, streaming platform Disney Plus offers films in IMAX format.
Acquisitions
In September 2022, IMAX acquired SSIMWAVE, a Canadian AI company that provides video quality technology company that spun out of the University of Waterloo, for approximately $21 million ($18.5 million in cash and $2.5 million in stock, plus up to $4 million in performance incenetives). SSIMWAVE's software assesses and enhances video quality for streaming and broadcast delivery, with clients including Disney, Paramount Global, Warner Bros. Discovery, and Comcast/NBCUniversal. IMAX CEO Richard Gelfond described the deal as part of a broader shift toward technology licensing, stating "we are not a theater exhibitor, but a technology licensing company."
IMAX China privatization attempt
In July 2023, IMAX Corporation announced a proposal to acquire full ownership of its Hong Kong-listed subsidiary, IMAX China, in which it already held a 71% stake. The offer valued the remaining shares at HK$10 per share in cash, a premium of roughly 49% over the 30-trading-day average closing price, for a total transaction value of approximately $124 million. IMAX cited weak appreciation of IMAX China's stock by Chinese capital markets and declining sell-side analyst coverage as motivations for the deal.
Although the proposal received 70% approval from shareholders shareholders, it fell short of the threshold required under Hong Kong takeover regulations, and the transaction was formally terminated. CEO Richard Gelfond said the company remained committed to its China operations and would explore alternative uses for the earmarked capital, including potential share buybacks of IMAX Corporation stock.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | IMAX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 73.15Y avg ≈12.2 | ≈12.2 | · | · | |
| P/S (TTM) | 7.05Y avg ≈3.5 | ≈3.5 | · | · | |
| P/B (MRQ) | 8.25Y avg ≈3.9 | ≈3.9 | · | · | |
| Price / FCF (TTM) | 23.15Y avg ≈113.2 | ≈113.2 | · | · | |
| Price / Cash Flow (TTM) | 22.05Y avg ≈53.4 | ≈53.4 | · | · | |
| Price / Tangible Book (MRQ) | 9.05Y avg ≈5.3 | ≈5.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | IMAX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 59.6%5Y avg ≈55.2% | ≈55.2% | · | · | |
| Operating Margin (TTM) | 20.2%5Y avg ≈9.8% | ≈9.8% | · | · | |
| EBITDA Margin (TTM) | 35.2%5Y avg ≈28.0% | ≈28.0% | · | · | |
| Pretax Margin (TTM) | 15.0%5Y avg ≈7.9% | ≈7.9% | · | · | |
| Net Profit Margin (TTM) | 9.8%5Y avg ≈1.3% | ≈1.3% | · | · | |
| ROA (TTM) | 4.6%5Y avg ≈1.1% | ≈1.1% | · | · | |
| ROE (TTM) | 12.1%5Y avg ≈3.2% | ≈3.2% | · | · | |
| ROIC | 17.9%5Y avg ≈7.5% | ≈7.5% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | IMAX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 16.5%5Y avg ≈27.8% | ≈27.8% | · | · | |
| Revenue CAGR 3Y | 10.9%5Y avg ≈20.7% | ≈20.7% | · | · | |
| Revenue CAGR 5Y | 24.5% | · | · | · | |
| EPS YoY | 31.2% | · | · | · | |
| Net Income YoY | 33.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | IMAX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.55Y avg ≈0.4 | ≈0.4 | · | · | |
| Inventory Turnover | 5.05Y avg ≈4.7 | ≈4.7 | · | · | |
| Receivables Turnover | 3.85Y avg ≈3.0 | ≈3.0 | · | · | |
| Revenue / Employee | ≈$604.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 22, 2026 | $0.43 | $0.29 | 50.8% |
| March 31, 2026 | $0.17 | $0.15 | 9.8% | |
| Dec. 31, 2025 | $0.58 | $0.46 | 25.1% | |
| Sept. 30, 2025 | $0.47 | $0.39 | 20.7% | |
| June 30, 2025 | $0.26 | $0.22 | 20.3% | |
| March 31, 2025 | $0.13 | $0.12 | 11.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $410M | $352M | $375M | $301M | $255M | $137M | $396M | $374M | $381M | $377M | $374M | $291M | |
| Cost of Revenue | $164M | $162M | $160M | $144M | $120M | $115M | $181M | $166M | $196M | $175M | $155M | $117M | |
| Gross Profit | $246M | $190M | $214M | $156M | $134M | $22M | $214M | $208M | $185M | $203M | $219M | $173M | |
| R&D Expense | $6M | $5M | $10M | $5M | $7M | $6M | $5M | $14M | $21M | $16M | $13M | $16M | |
| SG&A Expense | $138M | $133M | $144M | $138M | $117M | $108M | · | · | · | · | · | · | |
| Operating Income | $84M | $44M | $50M | $-5M | $11M | $-122M | $77M | $45M | $31M | $59M | $88M | $58M | |
| Interest Expense | · | · | $7M | $6M | $7M | $7M | $3M | $3M | $2M | $2M | $2M | $924.0K | |
| Interest Income | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $1M | $10M | $9M | $9M | |
| Pretax Income | $63M | $38M | $46M | $-10M | $11M | $-129M | $75M | $44M | $30M | $58M | $87M | $57M | |
| Income Tax | $18M | $5M | $13M | $10M | $21M | $27M | $17M | $10M | $17M | $16M | $20M | $14M | |
| Net Income | $35M | $26M | $25M | $-23M | $-22M | $-144M | $47M | $23M | $2M | $29M | $56M | $40M | |
| EPS (Basic) | $0.65 | $0.49 | $0.47 | $-0.40 | $-0.38 | $-2.43 | · | $0.36 | $0.04 | $0.43 | $0.79 | $0.58 | |
| EPS (Diluted) | $0.63 | $0.48 | $0.46 | $-0.40 | $-0.38 | $-2.43 | · | $0.36 | $0.04 | $0.42 | $0.78 | $0.56 | |
| Shares (Basic) | 53,636,000 | 52,650,000 | 54,310,000 | 56,674,000 | 59,126,000 | 59,237,000 | 61,310,000 | 63,075,000 | 65,380,000 | 67,575 | 69,526 | 68,346 | |
| Shares (Diluted) | 55,544,000 | 53,864,000 | 55,146,000 | 56,674,000 | 59,126,000 | 59,237,000 | 61,489,000 | 63,207,000 | 65,540,000 | 68,263 | 71,058 | 69,754 | |
| EBITDA | $147M | $109M | $110M | $52M | $67M | $-68M | $141M | $103M | $98M | $105M | $131M | $92M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $151M | $101M | $76M | $97M | $190M | $317M | $109M | $142M | $159M | $205M | $317M | $107M | |
| Receivables | $108M | $108M | $136M | $136M | $110M | $56M | $100M | $93M | $131M | $96M | $98M | $76M | |
| Inventory | $33M | $33M | $32M | $32M | $27M | $40M | $43M | $45M | $31M | $42M | $39M | $17M | |
| PP&E (Net) | $243M | $240M | $243M | $253M | $260M | $277M | $307M | $281M | $277M | $245M | $218M | $183M | |
| PP&E (Gross) | $523M | $506M | $513M | $519M | $512M | $501M | $498M | $452M | $428M | $378M | $328M | $290M | |
| Accum. Depreciation | $281M | $266M | $269M | $266M | $252M | $224M | $191M | $171M | $151M | $133M | $110M | $107M | |
| Goodwill | $46M | $53M | $53M | $53M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | |
| Intangibles | $32M | $35M | $35M | $33M | $23M | $26M | $30M | $34M | $31M | $30M | $29M | $28M | |
| Total Assets | $894M | $830M | $815M | $821M | $883M | $998M | $889M | $874M | $867M | $857M | $931M | $622M | |
| Deferred Tax | $13M | $13M | $13M | $15M | $18M | $19M | · | · | · | · | · | · | |
| Total Liabilities | $466M | $452M | $469M | $491M | $453M | $533M | $246M | $274M | $263M | $231M | $253M | $195M | |
| Long-term Debt | · | · | · | · | $2M | $306M | $18M | $38M | $25M | $27M | $29M | · | |
| Common Stock | $419M | $401M | $389M | $377M | $410M | $407M | $423M | $422M | $446M | $439M | $448M | $345M | |
| Paid-in Capital | · | · | · | · | · | · | · | $180M | $175M | $177M | $163M | $47M | |
| Retained Earnings | $-240M | $-275M | $-293M | $-293M | $-235M | $-203M | $-40M | $-85M | $-88M | $-47M | $20M | $-6M | |
| Treasury Stock | · | · | · | · | · | $11.0K | $4M | $916.0K | $5M | $2M | $0 | $0 | |
| AOCI | $-10M | $-17M | $-12M | $-10M | $3M | $988.0K | $-3M | $-4M | $-626.0K | $-5M | $-7M | $-3M | |
| Stockholders' Equity | $338M | $299M | $273M | $263M | $356M | $394M | $548M | $512M | $528M | $562M | $624M | $383M | |
| Liabilities + Equity | $894M | $830M | $815M | $821M | $883M | $998M | $889M | $874M | $867M | $857M | $931M | $622M | |
| Shares Outstanding | 53,921,676 | 52,946,200 | 53,260,276 | 54,148,614 | 58,653,642 | 58,921,008 | 61,175,852 | 61,434,000 | 64,696,000 | 66,160,000 | 69,673,244 | 68,988,050 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $62M | $66M | $60M | $57M | $56M | $53M | $63M | $57M | $67M | $46M | $43M | $34M | |
| Stock-based Comp | $27M | $23M | $24M | $27M | $26M | $22M | $23M | $23M | $23M | $30M | $22M | $15M | |
| Deferred Tax | $772.0K | $-6M | $-1M | $-2M | $3M | $24M | $7M | $-7M | $-4M | $5M | $-1M | $627.0K | |
| Amort. of Intangibles | $8M | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | $2M | $2M | $2M | |
| Restructuring | $2M | $4M | $3M | $0 | · | $0 | $628.0K | $2M | $10M | · | · | · | |
| Other Non-cash | $-5M | $-73M | $-85M | $-41M | $-59M | $-3M | $-95M | $49M | $11M | $-64M | $-72M | $3M | |
| Operating Cash Flow | $127M | $71M | $59M | $17M | $6M | $-23M | $90M | $110M | $85M | $78M | $84M | $87M | |
| CapEx | $8M | $8M | $6M | $8M | $4M | $697.0K | $7M | $13M | $24M | $15M | $43M | $40M | |
| Investing Cash Flow | $-42M | $-41M | $-32M | $-53M | $-7.0K | $-9M | $-66M | $-57M | $-74M | $-65M | $-79M | $-62M | |
| Stock Repurchased | · | · | · | · | $14M | $37M | $3M | $71M | $46M | $0 | $34M | $3M | |
| Net Stock Activity | · | · | · | · | $-14M | $-37M | $-3M | $-6M | $-46M | $-117M | $-34M | $-3M | |
| Financing Cash Flow | $-34M | $-6M | $-49M | $-59M | $-133M | $241M | $-57M | $-71M | $-58M | $-126M | $205M | $52M | |
| Net Change in Cash | $51M | $24M | $-21M | $-92M | $-128M | $208M | $-32M | $-17M | $-46M | $-113M | $211M | $77M | |
| Taxes Paid | $16M | $15M | $18M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $119M | $62M | $52M | $9M | $2M | $-24M | $83M | $97M | $61M | $63M | $40M | $47M | |
| Levered FCF | · | · | $47M | $-3M | $9M | $-32M | $81M | $94M | $60M | $61M | $39M | $46M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.0% | 54.0% | 57.2% | 52.0% | 52.7% | 15.7% | 54.1% | 55.5% | 48.6% | 53.7% | 58.7% | 59.7% | |
| Operating Margin | 20.5% | 12.4% | 13.5% | -1.6% | 4.3% | -88.9% | 19.5% | 12.1% | 8.1% | 15.4% | 23.5% | 19.9% | |
| Net Margin | 8.5% | 7.4% | 6.8% | -7.6% | -8.8% | -104.9% | 11.8% | 6.1% | 0.62% | 7.6% | 14.9% | 13.7% | |
| Pretax Margin | 15.4% | 10.7% | 12.3% | -3.2% | 4.3% | -94.2% | 19.0% | 11.7% | 7.9% | 15.3% | 23.3% | 19.7% | |
| EBITDA Margin | 35.8% | 31.1% | 29.5% | 17.2% | 26.3% | -49.8% | 35.6% | 27.4% | 25.7% | 27.7% | 34.9% | 31.5% | |
| ROA | 4.0% | 3.2% | 3.1% | -2.7% | -2.4% | -15.2% | 5.3% | 2.6% | 0.27% | 3.2% | 7.2% | 7.2% | |
| ROE | 10.9% | 9.1% | 9.4% | -7.4% | -5.9% | -30.8% | 8.8% | 4.4% | 0.43% | 4.9% | 11.1% | 11.3% | |
| ROIC | 17.9% | 12.7% | 13.2% | -3.7% | -2.7% | -38.1% | 11.0% | 6.9% | 2.6% | 7.4% | 10.8% | 11.3% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Coverage | · | · | 7.4 | -0.8 | 1.5 | -17.4 | 27.7 | 15.5 | 15.9 | 32.2 | 52.8 | 62.6 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.5 | 0.4 | 0.3 | 0.1 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | |
| Inventory Turnover | 5.0 | 5.0 | 5.1 | 4.9 | 3.6 | 2.8 | 4.1 | 4.4 | 5.4 | 4.3 | 5.5 | 8.7 | |
| Receivables Turnover | 3.8 | 2.9 | 2.8 | 2.4 | 3.1 | 1.8 | 4.1 | 3.3 | 3.4 | 3.9 | 4.3 | 3.9 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.27 | $5.66 | $5.13 | $4.86 | $6.07 | $6.54 | $8.95 | $8.34 | $8.16 | $8.49 | $8.95 | $5.55 | |
| Revenue / Share | $7.39 | $6.54 | $6.80 | $5.31 | $4.31 | $2.31 | $6.43 | $5923.41 | $5809.69 | $5527.65 | $5260.56 | $4.17 | |
| Cash Flow / Share | $2.29 | $1.32 | $1.06 | $0.31 | $0.10 | $-0.39 | $1.47 | $1739.87 | $1302.50 | $1140.76 | $1177.70 | $1.24 | |
| Cash / Share | $2.80 | $1.90 | $1.43 | $1.80 | $3.23 | $5.39 | $1.79 | $2.30 | $2.45 | $3.09 | $4.56 | $1.54 | |
| EPS (TTM) | $0.63 | $0.48 | $0.46 | $-0.40 | $-0.38 | $-2.43 | $0.36 | $0.36 | $0.04 | $0.42 | $0.78 | $0.56 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.5% | -6.0% | 24.6% | 18.0% | 86.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.9% | 11.4% | 39.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 24.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 31.2% | 4.3% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 33.8% | 2.9% | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $410M | $352M | $375M | $301M | $255M | $137M | $396M | $374M | $381M | $377M | $374M | $291M | |
| Net Income TTM | $35M | $26M | $25M | $-23M | $-22M | $-144M | $47M | $23M | $2M | $29M | $56M | $40M | |
| Market Cap | $1.99B | $1.36B | $800M | $794M | $1.05B | $1.06B | $1.25B | $1.16B | $1.50B | $2.08B | $2.48B | $2.13B | |
| P/E | 58.7 | 53.3 | 32.7 | -36.6 | -46.9 | -7.4 | 56.8 | 52.2 | 578.8 | 74.8 | 45.6 | 55.2 | |
| P/S | 4.9 | 3.8 | 2.1 | 2.6 | 4.1 | 7.7 | 3.2 | 3.1 | 3.9 | 5.5 | 6.6 | 7.3 | |
| P/B | 5.9 | 4.5 | 2.9 | 3.0 | 2.9 | 2.8 | 2.3 | 2.3 | 2.8 | 3.7 | 4.0 | 5.6 | |
| P / Tangible Book | 7.7 | 6.4 | 4.3 | 4.5 | 3.6 | 3.2 | · | · | · | · | · | · | |
| P / Cash Flow | 15.7 | 19.1 | 13.6 | 45.8 | 172.5 | -46.1 | 13.8 | 10.5 | 17.5 | 26.7 | 29.6 | 24.6 | |
| P / FCF | 16.8 | 21.7 | 15.3 | 89.2 | 422.8 | -44.8 | 15.1 | 12.0 | 24.5 | 33.2 | 61.2 | 45.8 | |
| Earnings Yield | 1.7% | 1.9% | 3.1% | -2.7% | -2.1% | -13.5% | 1.8% | 1.9% | 0.17% | 1.3% | 2.2% | 1.8% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $103M | $81M | $125M | $107M | $92M | $87M | $93M | $91M | $89M | $79M | $86M | $104M | $98M | $87M | $98M | $69M | |
| Cost of Revenue | $40M | $36M | $53M | $39M | $38M | $33M | $44M | $40M | $45M | $32M | $42M | $41M | $40M | $37M | $49M | $37M | |
| Gross Profit | $63M | $46M | $72M | $67M | $54M | $53M | $48M | $51M | $44M | $47M | $44M | $63M | $58M | $50M | $49M | $32M | |
| R&D Expense | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $-265.0K | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $1M | |
| SG&A Expense | $35M | $32M | $35M | $34M | $35M | $33M | $32M | $31M | $38M | $31M | $35M | $36M | $39M | $34M | $38M | $33M | |
| Operating Income | $21M | $10M | $24M | $29M | $14M | $17M | $10M | $19M | $3M | $12M | $3M | $22M | $14M | $11M | $8M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $1M | $2M | $2M | · | $1M | |
| Interest Income | $651.0K | $468.0K | $589.0K | $557.0K | $1M | $540.0K | $460.0K | $625.0K | $561.0K | $534.0K | $648.0K | $738.0K | $693.0K | $407.0K | $252.0K | $257.0K | |
| Pretax Income | $19M | $8M | $7M | $28M | $13M | $15M | $8M | $18M | $1M | $11M | $1M | $22M | $13M | $10M | $6M | $-5M | |
| Income Tax | $4M | $2M | $4M | $5M | $1M | $7M | $1M | $2M | $-4M | $5M | $-2M | $7M | $3M | $5M | $2M | $2M | |
| Net Income | $15M | $4M | $637.0K | $21M | $11M | $2M | $5M | $14M | $4M | $3M | $3M | $12M | $8M | $2M | $3M | $-9M | |
| EPS (Basic) | $0.28 | $0.08 | $0.02 | $0.38 | $0.21 | $0.04 | $0.10 | $0.26 | $0.07 | $0.06 | $0.05 | $0.22 | $0.15 | $0.05 | $0.04 | $-0.16 | |
| EPS (Diluted) | $0.27 | $0.07 | $0.02 | $0.37 | $0.20 | $0.04 | $0.09 | $0.26 | $0.07 | $0.06 | $0.05 | $0.22 | $0.15 | $0.04 | $0.04 | $-0.16 | |
| Shares (Basic) | 54,951,000 | 54,125,000 | · | 53,788,000 | 53,751,000 | 53,145,000 | · | 52,682,000 | 52,633,000 | 52,501,000 | · | 54,618,000 | 54,591,000 | 54,064,000 | · | 56,039,000 | |
| Shares (Diluted) | 56,569,000 | 56,392,000 | · | 55,565,000 | 55,161,000 | 54,969,000 | · | 54,089,000 | 53,428,000 | 53,406,000 | · | 55,535,000 | 55,320,000 | 54,991,000 | · | 56,039,000 | |
| EBITDA | $21M | $25M | · | $29M | $14M | $32M | · | $19M | $3M | $27M | · | $22M | $14M | $25M | · | $-4M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $146M | $151M | $143M | $109M | $97M | $101M | $105M | $92M | $81M | · | $110M | $95M | $99M | · | $87M | |
| Receivables | $115M | $109M | $108M | $108M | $127M | $122M | $108M | $114M | $122M | $141M | · | $136M | $126M | $123M | · | $126M | |
| Inventory | $39M | $36M | $33M | $41M | $37M | $32M | $33M | $38M | $38M | $36M | · | $45M | $37M | $37M | · | $36M | |
| PP&E (Net) | $239M | $241M | $243M | $244M | $244M | $245M | $240M | $245M | $238M | $240M | · | $238M | $239M | $248M | · | $252M | |
| PP&E (Gross) | · | · | $523M | · | · | · | $506M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $281M | · | · | · | $266M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $46M | $46M | $46M | $53M | $53M | $53M | $53M | $53M | $53M | $53M | · | $53M | $53M | $53M | · | $62M | |
| Intangibles | $30M | $31M | $32M | $33M | $34M | $35M | $35M | $34M | $35M | $35M | · | $34M | $34M | $33M | · | $22M | |
| Total Assets | $918M | $893M | $894M | $890M | $869M | $848M | $830M | $848M | $827M | $824M | · | $851M | $816M | $822M | · | $800M | |
| Deferred Tax | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | · | $13M | $14M | $16M | · | $15M | |
| Total Liabilities | $467M | $465M | $466M | $453M | $464M | $464M | $452M | $480M | $484M | $491M | · | $494M | $478M | $488M | · | $462M | |
| Common Stock | $441M | $430M | $419M | $416M | $415M | $414M | $401M | $395M | $394M | $394M | · | $390M | $390M | $390M | · | $389M | |
| Retained Earnings | $-231M | $-236M | $-240M | $-241M | $-261M | $-272M | $-275M | $-280M | $-294M | $-297M | · | $-272M | $-284M | $-292M | · | $-283M | |
| AOCI | $-7M | $-9M | $-10M | $-12M | $-14M | $-16M | $-17M | $-11M | $-14M | $-13M | · | $-15M | $-15M | $-8M | · | $-16M | |
| Stockholders' Equity | $356M | $335M | $338M | $350M | $320M | $300M | $299M | $289M | $267M | $259M | · | $287M | $271M | $264M | · | $273M | |
| Liabilities + Equity | $918M | $893M | $894M | $890M | $869M | $848M | $830M | $848M | $827M | $824M | · | $851M | $816M | $822M | · | $800M | |
| Shares Outstanding | 54,842,114 | 54,855,176 | 53,921,676 | 53,798,934 | 53,782,520 | 53,742,048 | 52,946,200 | 52,682,641 | 52,676,567 | 52,622,200 | 53,260,276 | 54,607,095 | 54,620,083 | 54,589,933 | 54,148,614 | 55,973,443 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $15M | $16M | $16M | $16M | $15M | $17M | $15M | $19M | $15M | $14M | $19M | $14M | $13M | $14M | $16M | |
| Stock-based Comp | $7M | $6M | $8M | $6M | $7M | $5M | $6M | $5M | $7M | $5M | $6M | $5M | $7M | $5M | $9M | $5M | |
| Deferred Tax | $273.0K | $-35.0K | $38.0K | $662.0K | $72.0K | $0 | $2M | $383.0K | $-8M | $571.0K | $2M | $-445.0K | $-3M | $-193.0K | $1M | $-3M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | $2M | $0 | $2M | $0 | $786.0K | $57.0K | $4M | $0 | $0 | $0 | · | · | · | $1M | · | · | |
| Other Non-cash | · | $-32M | · | · | · | $-18M | · | · | · | $-52M | · | · | · | $-9M | · | · | |
| Operating Cash Flow | $32M | $4M | $29M | $68M | $23M | $7M | $11M | $35M | $35M | $-11M | $4M | $29M | $5M | $21M | $17M | $6M | |
| CapEx | $21.0K | $2M | $1M | $3M | $2M | $2M | $5M | $1M | $2M | $1M | $4M | $2M | $645.0K | $364.0K | $3M | $2M | |
| Investing Cash Flow | $-6M | $-7M | $-7M | $-13M | $-7M | $-15M | $-11M | $-15M | $-8M | $-7M | $-13M | $-10M | $-4M | $-4M | $-13M | $-22M | |
| Stock Repurchased | · | · | · | · | · | $0 | · | $0 | $246.0K | $18M | · | $252.0K | $355.0K | $4M | · | $4M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-18M | · | · | · | $-4M | · | · | |
| Financing Cash Flow | $-12M | $-3M | $-14M | $-21M | $-4M | $4M | $-5M | $-8M | $-16M | $23M | $-24M | $-5M | $-5M | $-15M | $6M | $-7M | |
| Net Change in Cash | $14M | $-5M | $8M | $34M | $12M | $-4M | $-4M | $13M | $11M | $5M | $-33M | $14M | $-4M | $2M | $10M | $-23M | |
| Free Cash Flow | · | $2M | · | · | · | $5M | · | · | · | $-12M | · | · | · | $21M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $20M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.2% | 56.3% | · | 63.1% | 58.5% | 61.4% | · | 55.8% | 49.4% | 59.3% | · | 60.4% | 59.1% | 57.6% | · | 46.1% | |
| Operating Margin | 20.2% | 12.2% | · | 27.2% | 15.7% | 19.3% | · | 21.2% | 3.2% | 15.2% | · | 21.2% | 14.5% | 13.1% | · | -6.2% | |
| Net Margin | 15.0% | 5.2% | · | 19.4% | 12.3% | 2.7% | · | 15.2% | 4.0% | 4.1% | · | 11.5% | 8.5% | 2.8% | · | -13.0% | |
| Pretax Margin | 18.9% | 10.4% | · | 26.1% | 14.6% | 17.8% | · | 19.4% | 1.2% | 13.4% | · | 20.8% | 13.3% | 11.5% | · | -7.9% | |
| EBITDA Margin | 20.2% | 30.9% | · | 27.2% | 15.7% | 36.5% | · | 21.2% | 3.2% | 34.4% | · | 21.2% | 14.5% | 28.4% | · | -6.2% | |
| ROA | 1.7% | 0.49% | · | 2.4% | 1.3% | 0.28% | · | 1.6% | 0.44% | 0.40% | · | 1.5% | 1.0% | 0.29% | · | -1.1% | |
| ROE | 4.5% | 1.3% | · | 6.5% | 3.8% | 0.83% | · | 4.8% | 1.3% | 1.2% | · | 4.3% | 3.0% | 0.81% | · | -2.9% | |
| ROIC | 4.8% | 2.1% | · | 6.8% | 4.1% | 2.9% | · | 5.8% | 5.1% | 2.4% | · | 5.3% | 3.9% | 2.2% | · | -2.2% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Coverage | · | · | · | · | · | · | · | · | · | 6.2 | · | 14.9 | 7.9 | 6.5 | · | -3.2 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 1.1 | 1.1 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.2 | 0.9 | · | 1.0 | 1.1 | 1.1 | · | 1.0 | |
| Receivables Turnover | 0.9 | 0.7 | · | 1.0 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.6 | · | 0.8 | 0.8 | 0.7 | · | 0.7 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.49 | $6.12 | · | $6.50 | $5.96 | $5.57 | · | $5.49 | $5.07 | $4.92 | · | $5.26 | $4.96 | $4.84 | · | $4.88 | |
| Revenue / Share | $1.82 | $1.44 | · | $1.92 | $1.66 | $1.58 | · | $1.69 | $1.67 | $1.48 | · | $1.87 | $1.77 | $1.58 | · | $1226.91 | |
| Cash Flow / Share | · | $0.07 | · | · | · | $0.13 | · | · | · | $-0.21 | · | · | · | $0.39 | · | · | |
| Cash / Share | $2.92 | $2.66 | · | $2.66 | $2.03 | $1.81 | · | $1.98 | $1.74 | $1.54 | · | $2.01 | $1.74 | $1.82 | · | $1.56 | |
| EPS (TTM) | $0.73 | $0.66 | · | $0.70 | $0.59 | $0.46 | · | $0.44 | $0.40 | $0.48 | · | $0.45 | $0.07 | $-0.13 | · | $-0.27 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $416M | $405M | · | $378M | $362M | $360M | · | $346M | $358M | $367M | · | $387M | $352M | $328M | · | $311M | |
| Net Income TTM | $41M | $37M | · | $40M | $33M | $25M | · | $23M | $21M | $26M | · | $25M | $4M | $-7M | · | $-15M | |
| Market Cap | $2.19B | $2.09B | · | $1.76B | $1.50B | $1.42B | · | $1.08B | $883M | $851M | · | $1.06B | $928M | $1.05B | · | $790M | |
| P/E | 54.6 | 57.6 | · | 46.8 | 47.4 | 57.3 | · | 46.6 | 41.9 | 33.7 | · | 42.9 | 242.7 | -147.5 | · | -52.3 | |
| P/S | 5.3 | 5.1 | · | 4.7 | 4.1 | 3.9 | · | 3.1 | 2.5 | 2.3 | · | 2.7 | 2.6 | 3.2 | · | 2.5 | |
| P/B | 6.1 | 6.2 | · | 5.0 | 4.7 | 4.7 | · | 3.7 | 3.3 | 3.3 | · | 3.7 | 3.4 | 4.0 | · | 2.9 | |
| P / Tangible Book | 7.8 | 8.1 | · | 6.7 | 6.4 | 6.7 | · | 5.3 | 4.9 | 5.0 | · | 5.3 | 5.0 | 5.9 | · | 4.2 | |
| P / Cash Flow | · | 517.5 | · | · | · | 203.7 | · | · | · | -77.6 | · | · | · | 49.3 | · | · | |
| Earnings Yield | 1.8% | 1.7% | · | 2.1% | 2.1% | 1.8% | · | 2.1% | 2.4% | 3.0% | · | 2.3% | 0.41% | -0.68% | · | -1.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $410M | $352M | $375M | $301M | $255M |
| Gross Margin % | 60.0% | 54.0% | 57.2% | 52.0% | 52.7% |
| Operating Margin % | 20.5% | 12.4% | 13.5% | -1.6% | 4.3% |
| Net Income | $35M | $26M | $25M | $-23M | $-22M |
| Diluted EPS | $0.63 | $0.48 | $0.46 | $-0.40 | $-0.38 |
Not enough fundamentals data to build this statement yet.
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $119M | $62M | $52M | $9M | $2M |
Institutional owners (13F) 292 filers · $2.1B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 45 (-16 vs prior Q) | 35 (+1 vs prior Q) | 95 (+15 vs prior Q) | 77 (-7 vs prior Q) | +3.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Orbis Allan Gray Ltd | $205,261,262 | 5,149,555 | 9.83% | Shares |
| CONGRESS ASSET MANAGEMENT CO | $139,288,229 | 2,541,756 | 6.67% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $117,055,000 | 2,936,661 | 5.60% | Shares |
| BlackRock, Inc. | $115,880,676 | 2,907,192 | 5.55% | Shares |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $105,788,998 | 2,654,014 | 5.06% | Shares |
| Driehaus Capital Management LLC | $93,291,334 | 2,340,475 | 4.47% | Shares |
| FMR LLC | $92,570,866 | 2,322,400 | 4.43% | Shares |
| AMERIPRISE FINANCIAL INC | $70,604,012 | 1,771,297 | 3.38% | Shares |
| GOLDMAN SACHS GROUP INC | $65,971,732 | 1,655,086 | 3.16% | Shares |
| JPMORGAN CHASE & CO | $58,792,428 | 1,450,626 | 2.81% | Shares |
| ROYCE & ASSOCIATES LP | $53,541,068 | 1,343,228 | 2.56% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $50,458,881 | 1,265,843 | 2.42% | Shares |
| STATE STREET CORP | $38,428,866 | 963,761 | 1.84% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $38,322,919 | 961,438 | 1.83% | Shares |
| MARSHALL WACE, LLP | $33,523,654 | 841,035 | 1.60% | Shares |
| EMERALD ADVISERS, LLC | $33,002,685 | 827,965 | 1.58% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $31,895,693 | 800,193 | 1.53% | Shares |
| Nuveen, LLC | $28,997,871 | 727,493 | 1.39% | Shares |
| Nantahala Capital Management, LLC | $26,228,239 | 658,009 | 1.26% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $24,259,058 | 608,660 | 1.16% | Shares |
| VANGUARD GROUP INC | $22,980,471 | 621,766 | 1.10% | Shares |
| Pembroke Management, LTD | $21,500,177 | 392,339 | 1.03% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21,147,364 | 530,541 | 1.01% | Shares |
| EMERALD MUTUAL FUND ADVISERS TRUST | $20,965,802 | 525,986 | 1.00% | Shares |
| RAYMOND JAMES FINANCIAL INC | $20,177,769 | 506,216 | 0.97% | Shares |
| D. E. Shaw & Co., Inc. | $19,728,787 | 494,952 | 0.94% | Shares |
| AXIOM INVESTORS LLC /DE | $19,163,293 | 480,765 | 0.92% | Shares |
| Point72 Asset Management, L.P. | $17,538,400 | 440,000 | 0.84% | Put option |
| BANK OF AMERICA CORP /DE/ | $17,419,754 | 437,023 | 0.83% | Shares |
| AMERICAN CENTURY COMPANIES INC | $15,576,411 | 390,778 | 0.75% | Shares |
| WELLS FARGO & COMPANY/MN | $14,127,978 | 354,440 | 0.68% | Shares |
| BARCLAYS PLC | $14,030,720 | 352,000 | 0.67% | Put option |
| NORTHERN TRUST CORP | $13,187,761 | 330,852 | 0.63% | Shares |
| TWO SIGMA ADVISERS, LP | $13,072,752 | 353,700 | 0.63% | Shares |
| OBERWEIS ASSET MANAGEMENT INC/ | $13,015,845 | 326,539 | 0.62% | Shares |
| SEI INVESTMENTS CO | $11,940,634 | 299,546 | 0.57% | Shares |
| TWO SIGMA INVESTMENTS, LP | $11,217,441 | 281,421 | 0.54% | Shares |
| PRIMECAP MANAGEMENT CO/CA/ | $10,901,710 | 273,500 | 0.52% | Shares |
| RENAISSANCE GROUP LLC | $10,848,098 | 272,155 | 0.52% | Shares |
| BARCLAYS PLC | $10,031,607 | 251,671 | 0.48% | Shares |
| JANUS HENDERSON GROUP PLC | $9,923,587 | 261,059 | 0.48% | Shares |
| NOMURA HOLDINGS INC | $9,632,010 | 241,646 | 0.46% | Shares |
| Pier Capital, LLC | $9,480,980 | 237,857 | 0.45% | Shares |
| MORGAN STANLEY | $9,262,859 | 232,384 | 0.44% | Shares |
| OSAIC HOLDINGS, INC. | $8,897,702 | 223,224 | 0.43% | Shares |
| MARSICO CAPITAL MANAGEMENT LLC | $8,749,390 | 219,503 | 0.42% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $8,549,213 | 214,481 | 0.41% | Shares |
| Squarepoint Ops LLC | $8,306,864 | 208,401 | 0.40% | Shares |
| HBK INVESTMENTS L P | $8,058,098 | 202,160 | 0.39% | Shares |
| Decker Retirement Planning Inc. | $7,766,256 | 141,720 | 0.37% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Kevin Douglas, Michelle Douglas, James E. Douglas, III, K&M Douglas Trust, Irrevocable Descendant's Trust FBO Alexander James Douglas, Irrevocable Descendant's Trust FBO Amanda Anne Douglas, Irrevocable Descendant's Trust FBO Jake Edward Douglas, Irrevocable Descendant's Trust FBO Summer Jean Douglas, Nonexempt Trust FBO Kevin G. Douglas, Nonexempt Trust FBO James E. Douglas, III, Celtic Financial LLC ×12 filings | March 17, 2026 | 15.50% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 55 insiders · 34 officers · 15 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Richard L Gelfond | Chief Executive Officer | Aug. 19, 2026 C | 665,002 | 0 | 13 | $-42,564,873 |
| Daniel Manwaring | CEO, IMAX China Holding, Inc. | March 7, 2026 A | 12,363 | 0 | 0 | $0 |
| Greg Foster | CEO IMAX Entertain & ESVP IMAX | Dec. 9, 2018 M | 97,548 | 0 | 0 | $0 |
| Natasha Fernandes | Chief Financial Officer & EVP | Aug. 24, 2026 S | 35,596 | 0 | 2 | $-1,188,470 |
| Joseph Sparacio | Interim CFO | April 30, 2022 M | 16,240 | 0 | 0 | $0 |
| Patrick Mcclymont | CFO & EVP, Finance | March 7, 2021 A | 62,328 | 0 | 0 | $0 |
| Mark Welton | President IMAX Global Theatres | Aug. 25, 2026 S | 143,216 | 0 | 3 | $-4,360,126 |
| Megan Colligan | President, IMAX Entertainment | March 7, 2023 A | 119,434 | 0 | 0 | $0 |
| Don Savant | President Global Sales | March 7, 2018 A | 3,186 | 0 | 0 | $0 |
| Gary Moss | Chief Operating Officer | March 25, 2011 A | · | 0 | 0 | $0 |
| Giovanni M. Dolci | Chief Commercial Officer & EVP | Sept. 15, 2026 A | 41,027 | 0 | 1 | $-211,939 |
| Robert D Lister | Chief Legal Officer Sr Exec VP | Sept. 10, 2026 S | 182,375 | 0 | 2 | $-2,899,008 |
| Kenneth Ian Weissman | Deputy GC, Corp. Sec. & CCO | Aug. 25, 2026 S | 28,205 | 0 | 1 | $-436,320 |
| Calamera Pablo | CTO & EVP | Aug. 20, 2026 S | 43,012 | 0 | 2 | $-1,490,809 |
| Jonathan Fischer | Chief Content Officer | March 7, 2026 A | 3,419 | 0 | 0 | $0 |
| Michele Golden | Chief People Officer & EVP | March 7, 2026 A | 37,759 | 0 | 0 | $0 |
| Anne Globe | Chief Marketing Officer | March 7, 2026 A | 18,574 | 0 | 0 | $0 |
| Elizabeth Gitajn | SVP, Finance & Controller | March 7, 2024 A | 779 | 0 | 0 | $0 |
| Denny Tu | Chief Marketing Officer | May 1, 2023 S | 16,304 | 0 | 0 | $0 |
| Jacqueline Bassani | EVP & Chief People Officer | March 16, 2022 S | 20,610 | 0 | 0 | $0 |
| Kevin M Delaney | Sr VP, Finance & Controller | March 7, 2022 A | 5,078 | 0 | 0 | $0 |
| Jeff Vance | Sr VP, Finance & Controller | Dec. 1, 2019 M | 5,340 | 0 | 0 | $0 |
| Jl Pomeroy | Chief Marketing Officer | July 27, 2018 A | · | 0 | 0 | $0 |
| Mary G Ruby | Chief Administrative Officer | Dec. 31, 2017 E | 13,509 | 0 | 0 | $0 |
| Eileen Campbell | Chief Marketing Officer | March 7, 2017 M | 15,829 | 0 | 0 | $0 |
| Andrew Cripps | Executive Vice President | Dec. 30, 2016 M | 3,499 | 0 | 0 | $0 |
| Brian Bonnick | Chief Technology Officer | Nov. 5, 2015 C | 5,464 | 0 | 0 | $0 |
| Carrie Lindzon-Jacobs | Exec VP Human Resources | Oct. 30, 2015 C | 4,620 | 0 | 0 | $0 |
| Larry Oreilly | Exec VP, Worldwide Sales | May 14, 2015 C | 9,378 | 0 | 0 | $0 |
| David B Keighley | Chief Quality Officer | May 1, 2015 C | 4,547 | 0 | 0 | $0 |
| Jason Brenek | Executive Vice President | March 7, 2015 A | · | 0 | 0 | $0 |
| Edward Macneil | Sr Vice President, Finance | Nov. 15, 2013 C | 0 | 0 | 0 | $0 |
| Jean-Marc De Grandpre | Chief Marketing Officer | March 8, 2012 A | · | 0 | 0 | $0 |
| Vigna Vivekanand | Co-Controller | Dec. 31, 2007 A | · | 0 | 0 | $0 |
| Gail Berman | Director | June 11, 2026 M | 22,582 | 0 | 0 | $0 |
| Steve Pamon | Director | June 11, 2026 M | 35,515 | 0 | 0 | $0 |
| Jennifer L. Wong | Director | June 11, 2026 M | 22,582 | 0 | 0 | $0 |
| Darren D Throop | Director | June 11, 2026 M | 38,181 | 0 | 0 | $0 |
| Michael Macmillan | Director | June 11, 2026 M | 39,569 | 0 | 0 | $0 |
| Eric A Demirian | Director | June 11, 2026 M | 38,641 | 0 | 0 | $0 |
| David W Leebron | Director | June 11, 2026 M | 131,083 | 0 | 0 | $0 |
| Dana R Settle | Director | June 11, 2026 M | 69,090 | 0 | 0 | $0 |
| Bradley J Wechsler | Director | Dec. 14, 2020 G | 123,300 | 0 | 0 | $0 |
| Michael Lynne | Director | June 6, 2018 M | 27,008 | 0 | 0 | $0 |
| Martin Pompadur | Director | June 7, 2016 M | 16,708 | 0 | 0 | $0 |
| Garth Malcolm Girvan | Director | Dec. 5, 2014 S | 61,340 | 0 | 0 | $0 |
| Marc A Utay | Director | Aug. 14, 2014 C | 558,762 | 0 | 0 | $0 |
| Kenneth G Copland | Director | March 12, 2012 C | 0 | 0 | 0 | $0 |
| Jose Aleksandr Zlatar | · | Aug. 6, 2026 S | 583 | 0 | 1 | $-24,950 |
| Neil S Braun | · | June 4, 2020 M | 48,397 | 0 | 0 | $0 |
| Mary C Sullivan | · | March 10, 2006 A | 2,000 | 0 | 0 | $0 |
| Francis T Joyce | · | March 10, 2006 A | 7,500 | 0 | 0 | $0 |
| Kathryn A Gamble | · | Aug. 25, 2005 A | 0 | 0 | 0 | $0 |
| Michael J Fuchs | · | April 14, 2005 A | · | 0 | 0 | $0 |
| Brian Hall | · | Nov. 19, 2003 C | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 31 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| SAWS · ETF Series Solutions | 0.81% | 1,322 NS | July 31, 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0.51% | 5,163 NS | Aug. 31, 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0.16% | 43,433 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.16% | 433,470 SH | Sept. 11, 2026 | Daily |
| FCOM · FIDELITY COVINGTON TRUST | 0.13% | 47,091 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.11% | 49,426 SH | Aug. 19, 2026 | Daily |
| VOX · VANGUARD WORLD FUND | 0.11% | 160,324 SH | Aug. 19, 2026 | Daily |
| ESML · iShares Trust | 0.10% | 57,089 SH | Sept. 11, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.10% | 5,164 SH | Oct. 23, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.09% | 12,372 NS | July 31, 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.08% | 41,579 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.08% | 1,179,336 SH | Sept. 11, 2026 | Daily |
| ISCG · iShares Trust | 0.08% | 14,467 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.07% | 22,033 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 265,295 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.06% | 180,992 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.02% | 2,851 SH | Sept. 11, 2026 | Daily |
| DXUV · Dimensional ETF Trust | 0.02% | 2,046 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.01% | 36,362 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 112,260 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 6,308 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 3,393 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.01% | 13,028 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 1,881 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 13,977 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 9,698 SH | Sept. 9, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 36,802 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,701 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.00% | 10,216 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 2,072 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 16,964 SH | Sept. 2, 2026 | Daily |
IMAX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
12 analysts · 2026-10-23Mean target $60.00 +12.4%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| IMAX | $1.99B | 58.7 | 16.5% | 8.5% | 10.9% | 60.0% |
| LION | · | -13.7 | 1.8% | -7.5% | 27.2% | · |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
Live signal — the only filled card on screen.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.